Copy For Citation
Arslan G., Atasever T., CİNDORUK M., YILDIRIM İ. S.
Nuclear Medicine Communications, vol.22, no.9, pp.997-1001, 2001 (SCI-Expanded)
Article / Review
Nuclear Medicine Communications
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Cr-51 EDTA, intestinal permeability, ulcerative colitis, inflammatory bowel disease, INFLAMMATORY BOWEL-DISEASE, CR-51-LABELED ETHYLENEDIAMINETETRA-ACETATE, INCREASED INTESTINAL PERMEABILITY, CROHNS-DISEASE, CR-51 EDTA, LACTULOSE, RELATIVES, CALPROTECTIN, ABSORPTION, RHAMNOSE
Lokman Hekim University Affiliated:
Orally administered Cr-51-labelled ethylenediaminetetraacetic acid ((51)CrEDTA) has been used to evaluate intestinal permeability in inflammatory bowel disease, especially Crohn's disease. However, information about colonic permeability in ulcerative colitis (UC) is relatively scarce. The aim of this study was to investigate the urinary excretion of orally administered (51)CrEDTA, its relation to disease activity and its response to medical therapy in patients with UC.